Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Iovance Biotherapeutics Jumped 21.2% in December

TheMotleyFool

0 0

Here's Why Iovance Biotherapeutics Jumped 21.2% in December

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) gained over 21% last month, according to data from S&P Global Market Intelligence. There wasn't any company-specific news to send the pharma stock higher. Well, not any new news, anyway.

Investors continue to rally around shares of Iovance Biotherapeutics after the company reported impressive results for a top drug candidate in late November. The end-of-year rally helped the stock notch a 212% gain in 2019, but shares have given up nearly 8% in the new year. Does that suggest investors are getting a little ahead of themselves?

Image source: Getty Images.

Source Fool.com

Like: 0

IOVA

Share